Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations

MLA

Lutz J, et al. “Direct Oral Anticoagulants in Patients with Chronic Kidney Disease: Patient Selection and Special Considerations.” International Journal of Nephrology and Renovascular Disease, vol. ume 10, June 2017, pp. 135–43. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f20ade153aef4f28be2670589616f174&authtype=sso&custid=ns315887.

APA

Lutz J, Jurk K, & Schinzel H. (2017). Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations. International Journal of Nephrology and Renovascular Disease, ume 10, 135–143.

Chicago

Lutz J, Jurk K, and Schinzel H. 2017. “Direct Oral Anticoagulants in Patients with Chronic Kidney Disease: Patient Selection and Special Considerations.” International Journal of Nephrology and Renovascular Disease ume 10 (June): 135–43. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f20ade153aef4f28be2670589616f174&authtype=sso&custid=ns315887.